Beclomehasone Dipropionate 0.025%w/w + Salicylic Acid 3%w/w

Beclomehasone Dipropionate 0.025%w/w + Salicylic Acid 3%w/w is a topical formulation formulated with Beclomehasone Dipropionate 0.025%w/w + Salicylic Acid 3%w/w. The listed active ingredient profile is Beclomehasone Dipropionate w/w; Salicylic Acid w/w, placing the product in the keratolytic / dermatology category. The formulation contains keratolytic ingredients that help reduce excessive scale or thickened skin in approved dermatological uses. The dosage form is intended for topical/local application; the exact application site and frequency must follow the approved product instructions. For website cataloguing, the composition, strength, dosage form and formulation characteristics should be displayed prominently and consistently. The product description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and professional judgement. Prescription status, warnings, interactions, adverse effects and dosing or application instructions must be checked against the current approved product label. Manufacturer, licence, storage, shelf-life, reconstitution where applicable, and market-specific regulatory details should be added only from verified product documentation.